(NU/1433-33) GitLife Biotech: providing a lab-in-the-cloud versioning control system for engineered cell lines. Commercialisation of university research through provision of management skills to assist in successful spin-out company creation and scale-up
This is a contract result notice, not an open opportunity. Details from the official award data.
This sits in the lower-middle of the Business Services band — a mid-scale opportunity. Based on 57,319 valued Business Services tenders in our corpus.
Professor Krasnogor saw an opportunity in developing a solution to the "Integration" problem that is generic for biotechnology and the life sciences beyond the specifics of these two projects.
This is how the idea of establishing GitLife Biotech and the development of the CellRepo technology, as a versioning control system for engineered cell lines, including biotechnology microorganisms, in the cloud was born.
The plan is to spin out GitLife Biotech Ltd in Q3 2022.
To be able to spin out and take forward this opportunity, securing the involvement of experienced and appropriate business leadership is both essential and complementary to the existing technical staff and resource.
Commercial and business skills are needed in addition to those in the current team.
Moreover, it is clearly the case that Prof.
Krasnogor and the current team will need to remain focused on the scientific and technical aspects of the company and be able to place trust in and be guided by experienced staff (ideally with sector experience, networks and VC contacts) who will run the day-to-day business operations and company's strategic development.
Thus, a talented and experienced CEO (Designate) to assist in the development of the business plans and forecasting needed to spin out the company from the University, as well as to provide leadership of GitLife Biotech, is needed.
The person appointed to lead the company formation and development will have experience in business start -ups, deeptech companies or University Spin Outs, marketing, innovation and fund raising.
What the notice asks for
Professor Krasnogor saw an opportunity in developing
Professor Krasnogor saw an opportunity in developing a solution to the "Integration" problem that is generic for biotechnology and the life sciences beyond the specifics of these two projects.
To be able to spin out
To be able to spin out and take forward this opportunity, securing the involvement of experienced and appropriate business leadership is both essential and complementary to the existing technical staff and resource.
Thus, a talented and experienced CEO (Designate)
Thus, a talented and experienced CEO (Designate) to assist in the development of the business plans and forecasting needed to spin out the company from the University, as well as to provide leadership of GitLife Biotech, is needed.
The person appointed to lead the company
The person appointed to lead the company formation and development will have experience in business start -ups, deeptech companies or University Spin Outs, marketing, innovation and fund raising.
Sentences from the notice that state an obligation, surfaced automatically and shown in the order they appear. Not an exhaustive list — always confirm against the tender documents.
Make the case to bid
Reveal who to approach at Newcastle University, and generate a go-to-market strategy from their news, accounts and people.
Free to start. Named contacts come from published notices; the strategy is generated from the buyer’s news, accounts and people.
- OCID
- bf751771-139a-4d8d-8669-c52f4d174819
- Stage
- contract · Contract
- Source
- Contracts Finder
- Buyer ref
- NCL001-DN611994-45904593
Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.
Who wins this kind of work
The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.
Top suppliers & buyers in Business Services
Newcastle University’s tender network